vs
Side-by-side financial comparison of Distribution Solutions Group, Inc. (DSGR) and Bio-Techne (TECH). Click either name above to swap in a different company.
Distribution Solutions Group, Inc. is the larger business by last-quarter revenue ($518.0M vs $295.9M, roughly 1.8× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 1.2%, a 11.6% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs -6.4%). Over the past eight quarters, Distribution Solutions Group, Inc.'s revenue compounded faster (13.1% CAGR vs 4.2%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DSGR vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $518.0M | $295.9M |
| Net Profit | $6.5M | $38.0M |
| Gross Margin | 32.9% | 64.6% |
| Operating Margin | 4.6% | 18.4% |
| Net Margin | 1.2% | 12.8% |
| Revenue YoY | 10.7% | -6.4% |
| Net Profit YoY | -70.6% | 68.3% |
| EPS (diluted) | $0.14 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $518.0M | — | ||
| Q2 25 | $502.4M | $317.0M | ||
| Q1 25 | $478.0M | $316.2M | ||
| Q4 24 | $480.5M | $297.0M | ||
| Q3 24 | $468.0M | $289.5M | ||
| Q2 24 | $439.5M | $306.1M | ||
| Q1 24 | $416.1M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | $5.0M | $-17.7M | ||
| Q1 25 | $3.3M | $22.6M | ||
| Q4 24 | $-25.9M | $34.9M | ||
| Q3 24 | $21.9M | $33.6M | ||
| Q2 24 | $1.9M | $40.6M | ||
| Q1 24 | $-5.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 33.9% | 62.7% | ||
| Q1 25 | 34.3% | 67.9% | ||
| Q4 24 | 33.3% | 65.3% | ||
| Q3 24 | 33.9% | 63.2% | ||
| Q2 24 | 34.5% | 66.4% | ||
| Q1 24 | 34.5% | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.3% | -7.5% | ||
| Q1 25 | 4.2% | 12.2% | ||
| Q4 24 | 4.2% | 16.0% | ||
| Q3 24 | 4.0% | 13.8% | ||
| Q2 24 | 3.2% | 15.0% | ||
| Q1 24 | 0.7% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.0% | -5.6% | ||
| Q1 25 | 0.7% | 7.1% | ||
| Q4 24 | -5.4% | 11.7% | ||
| Q3 24 | 4.7% | 11.6% | ||
| Q2 24 | 0.4% | 13.3% | ||
| Q1 24 | -1.3% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.14 | — | ||
| Q2 25 | $0.11 | $-0.11 | ||
| Q1 25 | $0.07 | $0.14 | ||
| Q4 24 | $-0.55 | $0.22 | ||
| Q3 24 | $0.46 | $0.21 | ||
| Q2 24 | $0.04 | $0.26 | ||
| Q1 24 | $-0.11 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.2M | $172.9M |
| Total DebtLower is stronger | $665.5M | $260.0M |
| Stockholders' EquityBook value | $653.9M | $2.0B |
| Total Assets | $1.8B | $2.5B |
| Debt / EquityLower = less leverage | 1.02× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $69.2M | — | ||
| Q2 25 | $47.4M | $162.2M | ||
| Q1 25 | $65.4M | $140.7M | ||
| Q4 24 | $66.5M | $177.5M | ||
| Q3 24 | $61.3M | $187.5M | ||
| Q2 24 | $46.8M | $152.9M | ||
| Q1 24 | $73.1M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $665.5M | — | ||
| Q2 25 | $675.0M | $346.0M | ||
| Q1 25 | $712.4M | $330.0M | ||
| Q4 24 | $693.9M | $300.0M | ||
| Q3 24 | $704.1M | $300.0M | ||
| Q2 24 | $573.7M | $319.0M | ||
| Q1 24 | $535.7M | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $653.9M | — | ||
| Q2 25 | $649.4M | $1.9B | ||
| Q1 25 | $636.7M | $2.0B | ||
| Q4 24 | $640.5M | $2.1B | ||
| Q3 24 | $680.8M | $2.1B | ||
| Q2 24 | $653.3M | $2.1B | ||
| Q1 24 | $654.7M | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.6B | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.8B | $2.7B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.5B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 1.04× | 0.18× | ||
| Q1 25 | 1.12× | 0.16× | ||
| Q4 24 | 1.08× | 0.14× | ||
| Q3 24 | 1.03× | 0.14× | ||
| Q2 24 | 0.88× | 0.15× | ||
| Q1 24 | 0.82× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.4M | — |
| Free Cash FlowOCF − Capex | $32.9M | — |
| FCF MarginFCF / Revenue | 6.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $38.4M | — | ||
| Q2 25 | $33.3M | $98.2M | ||
| Q1 25 | $-4.8M | $41.1M | ||
| Q4 24 | $45.7M | $84.3M | ||
| Q3 24 | $-17.3M | $63.9M | ||
| Q2 24 | $21.4M | $75.5M | ||
| Q1 24 | $6.6M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $32.9M | — | ||
| Q2 25 | $28.7M | $93.3M | ||
| Q1 25 | $-10.4M | $31.0M | ||
| Q4 24 | $41.1M | $77.5M | ||
| Q3 24 | $-20.5M | $54.7M | ||
| Q2 24 | $18.0M | $57.5M | ||
| Q1 24 | $4.2M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 5.7% | 29.4% | ||
| Q1 25 | -2.2% | 9.8% | ||
| Q4 24 | 8.6% | 26.1% | ||
| Q3 24 | -4.4% | 18.9% | ||
| Q2 24 | 4.1% | 18.8% | ||
| Q1 24 | 1.0% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 1.2% | 3.2% | ||
| Q4 24 | 1.0% | 2.3% | ||
| Q3 24 | 0.7% | 3.2% | ||
| Q2 24 | 0.8% | 5.9% | ||
| Q1 24 | 0.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 5.95× | — | ||
| Q2 25 | 6.66× | — | ||
| Q1 25 | -1.46× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | -0.79× | 1.90× | ||
| Q2 24 | 11.28× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
